These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19281874)

  • 21. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
    Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-å crystal structure.
    Shi W; Schramm VL; Almo SC
    J Biol Chem; 1999 Jul; 274(30):21114-20. PubMed ID: 10409664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosomal nucleoside hydrolase. A novel mechanism from the structure with a transition-state inhibitor.
    Degano M; Almo SC; Sacchettini JC; Schramm VL
    Biochemistry; 1998 May; 37(18):6277-85. PubMed ID: 9572842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional structure of the inosine-uridine nucleoside N-ribohydrolase from Crithidia fasciculata.
    Degano M; Gopaul DN; Scapin G; Schramm VL; Sacchettini JC
    Biochemistry; 1996 May; 35(19):5971-81. PubMed ID: 8634238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosomal nucleoside hydrolase. Resonance Raman spectroscopy of a transition-state inhibitor complex.
    Deng H; Chan AW; Bagdassarian CK; Estupiñán B; Ganem B; Callender RH; Schramm VL
    Biochemistry; 1996 May; 35(19):6037-47. PubMed ID: 8634245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the molecular electrostatic potential surface of an enzymatic transition state with novel transition-state inhibitors.
    Horenstein BA; Schramm VL
    Biochemistry; 1993 Sep; 32(38):9917-25. PubMed ID: 8399161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and evaluation of dihydroxytetrahydro-1H-pyrrolo[2,1-c]- [1,4]benzothiazines as conformationally restricted transition-state inhibitors of beta-ribosidases.
    Gao L; Hollingsworth RI
    J Org Chem; 2005 Oct; 70(22):9013-6. PubMed ID: 16238341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.
    Goeminne A; McNaughton M; Bal G; Surpateanu G; Van der Veken P; De Prol S; Versées W; Steyaert J; Apers S; Haemers A; Augustyns K
    Bioorg Med Chem Lett; 2007 May; 17(9):2523-6. PubMed ID: 17317181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases.
    Evans GB; Furneaux RH; Gainsford GJ; Hanson JC; Kicska GA; Sauve AA; Schramm VL; Tyler PC
    J Med Chem; 2003 Jan; 46(1):155-60. PubMed ID: 12502369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein mimicry of DNA from crystal structures of the uracil-DNA glycosylase inhibitor protein and its complex with Escherichia coli uracil-DNA glycosylase.
    Putnam CD; Shroyer MJ; Lundquist AJ; Mol CD; Arvai AS; Mosbaugh DW; Tainer JA
    J Mol Biol; 1999 Mar; 287(2):331-46. PubMed ID: 10080896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
    J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and biochemical characterization of the nucleoside hydrolase from C. elegans reveals the role of two active site cysteine residues in catalysis.
    Singh RK; Steyaert J; Versées W
    Protein Sci; 2017 May; 26(5):985-996. PubMed ID: 28218438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?
    Berg M; Van der Veken P; Goeminne A; Haemers A; Augustyns K
    Curr Med Chem; 2010; 17(23):2456-81. PubMed ID: 20491648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the effector protein XOO4466 from Xanthomonas oryzae.
    Yu S; Hwang I; Rhee S
    J Struct Biol; 2013 Nov; 184(2):361-6. PubMed ID: 24007778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and mechanism of the 6-oxopurine nucleosidase from Trypanosoma brucei brucei.
    Vandemeulebroucke A; Minici C; Bruno I; Muzzolini L; Tornaghi P; Parkin DW; Versées W; Steyaert J; Degano M
    Biochemistry; 2010 Oct; 49(41):8999-9010. PubMed ID: 20825170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural comparison of MTA phosphorylase and MTA/AdoHcy nucleosidase explains substrate preferences and identifies regions exploitable for inhibitor design.
    Lee JE; Settembre EC; Cornell KA; Riscoe MK; Sufrin JR; Ealick SE; Howell PL
    Biochemistry; 2004 May; 43(18):5159-69. PubMed ID: 15122881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catalysis by nucleoside hydrolases.
    Versées W; Steyaert J
    Curr Opin Struct Biol; 2003 Dec; 13(6):731-8. PubMed ID: 14675552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple transients in the pre-steady-state of nucleoside hydrolase reveal complex substrate binding, product base release, and two apparent rates of chemistry.
    Vandemeulebroucke A; Versées W; Steyaert J; Barlow JN
    Biochemistry; 2006 Aug; 45(30):9307-18. PubMed ID: 16866377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electronic nature of the transition state for nucleoside hydrolase. A blueprint for inhibitor design.
    Horenstein BA; Schramm VL
    Biochemistry; 1993 Jul; 32(28):7089-97. PubMed ID: 8343502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational design of transition-state analogues as potent enzyme inhibitors with therapeutic applications.
    Amyes TL; Richard JP
    ACS Chem Biol; 2007 Nov; 2(11):711-4. PubMed ID: 18030986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.